Zhejiang Chimin Pharm Co Ltd

Zhejiang Chimin Pharm Co Ltd

603222 · SHG · Healthcare / Medical Instruments & Supplies

7.10CNY+0.01 (+0.14%)

Price History

Full chart

Market Stats

Previous Close7.09
Open7.09
Day Range6.96 – 7.13
52-Week Range6.95 – 12.36
Volume7.82M
Market Cap4.24B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.47
Dividend Yield0.00%
Beta0.37
50-Day Avg8.20
200-Day Avg8.95

About

Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells in vitro diagnostic products and provides medical services in China and internationally. The company provides non-PVC double-pipe double-valve, single-pipe single-valve, and single-pipe double-valve soft bags; plastic bottles; and other packaging forms. It also offers injection puncture medical devices, including safety syringes, safety injection needles, sterile syringes, irrigators, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and other products. In addition, the company provides in vitro diagnostics products, such as clinical chemical diagnostic, immunological diagnostic, blood testing, rapid diagnostic, and enzyme-linked immunological diagnostic reagents; laboratory instruments; and in vitro diagnostic medical products, as well as FOB fecal occult blood automated immunoassay monitoring and pylori Helicobacter detection kits. Further, it offers hemodialysis series products, including hemodialysis concentrate, and other products; and medical and health services. The company was formerly known as Zhejiang Chimin Pharmaceutical Co.,Ltd. and changed its name to Chimin Health Management Co., Ltd. in August 2018. Chimin Health Management Co., Ltd. was founded in 1996 and is based in Taizhou, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Yunfei Tian
  • Employees1.89K
  • HeadquartersNo. 888, Beiyuan Road, Taizhou, China, 318020, China
  • Websitehttps://www.chimin.cn

Leadership

  • Mr. Yunfei TianPresident & Director · b. 1982
  • Mr. Yang GuoweiFinancial Director · b. 1983
  • Mr. Gao Peng QiuExecutive VP & Director · b. 1974
  • Mr. Fudan ShangguanEmployee Representative Director & Production Director · b. 1979
  • Mr. Kun ChenDirector, VP & Board Secretary · b. 1983
  • Mr. Yong BieVice President · b. 1976
  • Hewei WangAccounting Supervisor

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue548.36M582.75M559.42M488.31M448.60M450.38M602.90M697.83M771.28M877.64M1.10B837.24M894.51M775.73M685.96M
Growth (%)-+6.27%-4.00%-12.71%-8.13%+0.40%+33.86%+15.75%+10.53%+13.79%+25.16%-23.78%+6.84%-13.28%-11.57%
Cost of Revenue292.25M307.24M283.18M252.71M231.38M245.69M331.57M409.67M420.08M520.76M572.59M451.04M515.70M496.13M472.97M
Gross Profit256.11M275.51M276.24M235.60M217.22M204.69M271.33M288.16M351.20M356.88M525.88M386.20M378.81M279.60M212.99M
Gross Margin46.71%47.28%49.38%48.25%48.42%45.45%45.00%41.29%45.53%40.66%47.87%46.13%42.35%36.04%31.05%
Operating Expense178.31M178.12M183.58M168.42M155.75M157.61M197.21M233.04M260.47M325.39M358.33M340.23M422.64M343.18M307.31M
Operating Income77.80M97.39M92.66M67.18M61.47M47.08M74.12M55.11M90.72M31.49M167.55M45.97M-43.83M-63.58M-94.32M
Operating Margin14.19%16.71%16.56%13.76%13.70%10.45%12.29%7.90%11.76%3.59%15.25%5.49%-4.90%-8.20%-13.75%
EBITDA123.10M101.10M128.64M101.12M89.83M79.35M120.69M124.50M191.75M116.65M291.88M145.25M64.91M54.25M-99.50M
EBITDA Margin22.45%17.35%23.00%20.71%20.02%17.62%20.02%17.84%24.86%13.29%26.57%17.35%7.26%6.99%-14.51%
Net Income67.78M74.56M81.25M57.58M51.75M40.89M52.88M32.06M69.20M6.40M147.52M34.46M-65.48M-59.71M-245.58M
Net Income Margin12.36%12.79%14.52%11.79%11.54%9.08%8.77%4.59%8.97%0.73%13.43%4.12%-7.32%-7.70%-35.80%
R&D17.31M18.01M18.25M18.44M19.33M19.32M19.29M17.07M21.34M22.44M30.00M28.38M28.90M41.61M47.92M
R&D as % of Total Revenue3.16%3.09%3.26%3.78%4.31%4.29%3.20%2.45%2.77%2.56%2.73%3.39%3.23%5.36%6.99%
Interest Expense16.35M13.01M5.97M4.42M537.96K388.71K12.97M22.07M33.35M40.36M39.01M29.86M23.79M21.73M20.67M
Interest Expense % of Total Revenue2.98%2.23%1.07%0.91%0.12%0.09%2.15%3.16%4.32%4.60%3.55%3.57%2.66%2.80%3.01%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets655.30M690.63M713.38M630.04M844.01M922.43M1.57B2.12B2.08B2.29B2.43B2.71B2.48B2.41B2.31B
Total Liabilities272.26M258.10M225.24M188.49M93.02M113.49M646.63M1.08B1.01B1.25B1.05B939.64M820.13M846.22M1.00B
Total Equity383.04M432.53M488.13M441.55M721.03M751.24M793.44M809.72M872.09M864.75M1.24B1.71B1.58B1.48B1.22B
Cash30.46M105.75M125.79M118.92M260.31M240.89M179.57M139.40M149.42M242.95M278.52M649.31M251.18M313.23M295.28M
Total Debt182.00M157.00M125.00M125.00M19.61M2.20M339.51M714.77M725.78M796.17M649.73M597.25M459.83M502.78M-
Net Debt151.54M51.25M-787.74K6.08M-240.70M-238.69M159.94M575.37M576.37M553.22M371.21M-52.05M208.65M189.54M337.68M

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow32.90M169.88M108.19M77.36M87.46M72.12M66.49M123.99M152.77M166.29M289.49M204.65M140.20M72.99M-10.35M
Investing Cash Flow-28.36M-31.86M-28.22M-36.10M-87.53M-111.81M-526.11M-496.60M-94.86M-136.64M-255.54M-165.42M-248.37M-6.70M-
Financing Cash Flow-36.44M-62.63M-62.93M-46.42M135.91M17.98M397.82M331.35M-52.56M50.59M14.61M329.21M-291.84M-5.90M-
Capital Expenditure26.13M32.11M31.10M38.47M105.88M97.64M334.74M260.85M134.16M167.76M296.74M196.11M149.22M122.01M46.22M
Free Cash Flow6.77M137.77M77.08M38.89M-18.41M-25.53M-268.25M-136.86M18.62M-1.46M-7.25M8.54M-9.02M-49.03M-56.57M
Dividends Paid13.45M12.56M35.29M40.26M24.66M10.46M24.92M43.96M6.72M15.36M37.97M30.67M10.74M16.69M19.76M
FCF to OCF20.58%81.10%71.25%50.27%-21.05%-35.40%-403.42%-110.38%12.19%-0.88%-2.51%4.17%-6.43%-67.17%546.46%
Dividend Paid to FCF198.57%9.12%45.78%103.54%-133.90%-40.99%-9.29%-32.12%36.10%-1048.85%-523.51%359.00%-119.14%-34.05%-34.93%

Earnings

Report DateMar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Aug 21, 2020Oct 23, 2020Dec 31, 2020Apr 28, 2021Aug 20, 2021Oct 22, 2021Mar 23, 2022Apr 21, 2022Aug 29, 2022Oct 26, 2022Dec 31, 2022Apr 19, 2023Jul 24, 2023
EPS Estimate----------------------------------
EPS Actual0.030.030.040.030.020.010.030.030.020.030.040.030.030.040.02-0.010.030.030.040.06-0.020.060.10-0.060.120.190.120.010.15-0.010.03-0.09-0.090.01
Surprise----------------------------------
Timing------------------------After-hours--After-hoursAfter-hoursPre-marketAfter-hours-Pre-marketPre-market

Key Statistics & Ratios

Market Cap4.24B
Enterprise Value5.08B
Trailing P/E0.00
Forward P/E0.00
Price / Sales6.45
Price / Book4.31
EPS-0.47
Book Value2.12
Revenue (TTM)657.15M
Gross Profit (TTM)170.35M
EBITDA-39.26M
Profit Margin-36.87%
Operating Margin-10.66%
Return on Equity-18.44%
Return on Assets-3.58%
Shares Outstanding525.09M
Shares Float290.13M
Beta0.37
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
0.02Jun 7, 2023
20221×
0.09Jun 20, 2022
20201×
0.03Jun 16, 2020
20191×
0.01Jul 4, 2019
20181×
0.04Aug 10, 2018
20171×
0.03Jul 13, 2017
20161×
0.05Jun 21, 2016
20151×
0.05Jun 12, 2015

Stock Splits

  • Jun 20, 2022188394:134567
  • Jun 21, 20162:1